CytoDyn CYDY Stock
CytoDyn Price Chart
CytoDyn CYDY Financial and Trading Overview
| CytoDyn stock price | 0.3 USD |
| Previous Close | 0.3 USD |
| Open | 0.3 USD |
| Bid | 0.29 USD x 650000 |
| Ask | 0.3 USD x 250000 |
| Day's Range | 0.29 - 0.3 USD |
| 52 Week Range | 0.21 - 0.4 USD |
| Volume | 1.45M USD |
| Avg. Volume | 1.91M USD |
| Market Cap | 402.15M USD |
| Beta (5Y Monthly) | 1.151 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CYDY Valuation Measures
| Enterprise Value | 419.76M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.631111 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -19.617 |
Trading Information
CytoDyn Stock Price History
| Beta (5Y Monthly) | 1.151 |
| 52-Week Change | -14.28% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 0.4 USD |
| 52 Week Low | 0.21 USD |
| 50-Day Moving Average | 0.31 USD |
| 200-Day Moving Average | 0.28 USD |
CYDY Share Statistics
| Avg. Volume (3 month) | 1.91M USD |
| Avg. Daily Volume (10-Days) | 2.17M USD |
| Shares Outstanding | 1.37B |
| Float | 1.37B |
| Short Ratio | N/A |
| % Held by Insiders | 0.012% |
| % Held by Institutions | 0.022% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2025 |
| Most Recent Quarter (mrq) | February 28, 2026 |
| Next Fiscal Year End | May 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -67.44% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -21398000 USD |
| Net Income Avi to Common (ttm) | -40276000 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.66M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 28.82M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.366 |
| Book Value Per Share (mrq) | -0.077 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17982000 USD |
| Levered Free Cash Flow (ttm) | -4845625 USD |
Profile of CytoDyn
| Country | United States |
| State | WA |
| City | Vancouver |
| Address | 1111 Main Street |
| ZIP | 98660 |
| Phone | 360 980 8524 |
| Website | https://www.cytodyn.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has a collaboration with Creatv Bio. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
Q&A For CytoDyn Stock
What is a current CYDY stock price?
CytoDyn CYDY stock price today per share is 0.3 USD.
How to purchase CytoDyn stock?
You can buy CYDY shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CytoDyn?
The stock symbol or ticker of CytoDyn is CYDY.
Which industry does the CytoDyn company belong to?
The CytoDyn industry is Biotechnology.
How many shares does CytoDyn have in circulation?
The max supply of CytoDyn shares is 1.37B.
What is CytoDyn Price to Earnings Ratio (PE Ratio)?
CytoDyn PE Ratio is now.
What was CytoDyn earnings per share over the trailing 12 months (TTM)?
CytoDyn EPS is -0.04 USD over the trailing 12 months.
Which sector does the CytoDyn company belong to?
The CytoDyn sector is Healthcare.